Graft-versus-leukaemia reactivity induced by alloimmunisation without augmentation of graft-versus-host reactivity.
about
A history of haemopoietic cell transplantation.Blockade of interleukin-23 signaling results in targeted protection of the colon and allows for separation of graft-versus-host and graft-versus-leukemia responses.Donor lymphocyte infusions to treat hematologic malignancies in relapse after allogeneic blood or marrow transplantation.Allogeneic bone marrow transplantation with reduced conditioning (RC-BMT).Immunodominant minor histocompatibility antigens expressed by mouse leukemic cells can serve as effective targets for T cell immunotherapy.Adoptive transfer of unselected or leukemia-reactive T-cells in the treatment of relapse following allogeneic hematopoietic cell transplantation.Trying to overcome residual disease after bone marrow transplantation for hematologic malignancies.CD8(+) minor histocompatibility antigen-specific cytotoxic T lymphocyte clones eliminate human acute myeloid leukemia stem cellsA long road of T-cells to cure cancer: from adoptive immunotherapy with unspecific cellular products to donor lymphocyte infusions and transfer of engineered tumor-specific T-cells.The graft-versus-lymphoma effect: clinical review and future opportunities.Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cellsHLA identical leukemia cells and T cell growth factor activate cytotoxic T cell recognition of minor locus histocompatibility antigens in vitro.Mouse models of bone marrow transplantationSuicide gene therapy for graft-versus-host disease.Graft-versus-host disease.Graft-versus-leukemia reactions in clinical bone marrow transplantation.Next generation HLA-haploidentical HSCT.The role of antigen-presenting cells in triggering graft-versus-host disease and graft-versus-leukemia.Specific depletion of mature T lymphocytes from human bone marrow.Reduced-intensity stem cell transplantation from an HLA-identical sibling donor in patients with myeloid malignancies.Intentional induction of mixed haematopoietic chimerism as platform for cellular therapy after HLA-matched allogeneic stem cell transplantation in childhood leukaemia patients.Myeloma-reactive allospecific cytotoxic T lymphocytes lyse target cells via the granule exocytosis pathway.Bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: importance of a graft-versus-leukaemia effect.NOTCH and Graft-Versus-Host Disease
P2860
Q33610841-0AA856D2-F34F-4BB4-A629-1581C6D10671Q33944262-4F96A46C-1413-4119-971B-25C81E95EF9FQ34124707-AB1A62B7-6EE5-46F7-86A0-35110EFFA18CQ34135678-8CCDC8B7-DCD5-4DDC-98B8-2C220A2C6943Q34207168-9B39D8B9-E2E7-4495-93A1-5729CB5BAC35Q34279672-BD864402-ECF5-446F-8D06-13C8C3AC6708Q35169842-ABD2A058-D285-4AF8-B5C2-35AF6F11AA3BQ35558987-4AE0CCF7-5465-43D8-90EA-3C3147C74C74Q36062047-35E4911C-2533-4E50-8588-38FB4FB507EAQ36128232-64A13845-75C1-4A20-BE3D-6453BD6F29EDQ36868712-F1FD8261-F391-403A-AAF0-6ED70A0994E3Q36990228-2E617253-81E6-4695-A91E-8158B6F38772Q37045969-6C594A6F-E2BC-44BD-B6C9-458D6499B926Q37773293-C64737EA-C110-47AC-85FB-73374FA80680Q39839304-ADC5E26B-F4ED-48FB-B919-13B962B76E85Q40860389-E62047D6-3C03-4115-BD91-F2CF07036D60Q41697436-3DE8F636-DC12-4D92-ABFF-39F67AB2953DQ42151172-25230525-48CB-4AC3-93BF-3E71E10D1BB6Q44264728-1B30E61B-7B2C-475C-8C7A-34E1F1E83B7EQ44817216-8146C5B0-F173-44B6-9A33-546783039F48Q46871229-8C6E2916-86A7-490E-B193-5FA8F8245A8DQ52827001-329D5B18-38C2-4AAB-ADF1-6BD4B86138DAQ54200942-DCB118D3-D6EC-4A24-B8AC-5B90A33B3F0CQ58789958-441A02B9-C0C5-4F2B-A948-525BEB34EA49
P2860
Graft-versus-leukaemia reactivity induced by alloimmunisation without augmentation of graft-versus-host reactivity.
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
1979年论文
@zh
1979年论文
@zh-cn
name
Graft-versus-leukaemia reactiv ...... graft-versus-host reactivity.
@en
type
label
Graft-versus-leukaemia reactiv ...... graft-versus-host reactivity.
@en
prefLabel
Graft-versus-leukaemia reactiv ...... graft-versus-host reactivity.
@en
P2093
P356
P1433
P1476
Graft-versus-leukaemia reactiv ...... graft-versus-host reactivity.
@en
P2093
P2888
P304
P356
10.1038/281490A0
P407
P577
1979-10-01T00:00:00Z
P6179
1023725182